In addition, it has been suggested that P53 gene mutations trigger progression from differentiated to anaplastic carcinoma in human thyroid glands [51]; P53 is particularly hypermutable in thyroid cancer [52]. Here, TP53 is linked to undifferentiated carcinoma.